These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 1309596

  • 1. Purification of core-binding factor, a protein that binds the conserved core site in murine leukemia virus enhancers.
    Wang SW, Speck NA.
    Mol Cell Biol; 1992 Jan; 12(1):89-102. PubMed ID: 1309596
    [Abstract] [Full Text] [Related]

  • 2. Cloning and characterization of subunits of the T-cell receptor and murine leukemia virus enhancer core-binding factor.
    Wang S, Wang Q, Crute BE, Melnikova IN, Keller SR, Speck NA.
    Mol Cell Biol; 1993 Jun; 13(6):3324-39. PubMed ID: 8497254
    [Abstract] [Full Text] [Related]

  • 3. Two factors that bind to highly conserved sequences in mammalian type C retroviral enhancers.
    Manley NR, O'Connell M, Sun W, Speck NA, Hopkins N.
    J Virol; 1993 Apr; 67(4):1967-75. PubMed ID: 8445718
    [Abstract] [Full Text] [Related]

  • 4. Indistinguishable nuclear factor binding to functional core sites of the T-cell receptor delta and murine leukemia virus enhancers.
    Redondo JM, Pfohl JL, Hernandez-Munain C, Wang S, Speck NA, Krangel MS.
    Mol Cell Biol; 1992 Nov; 12(11):4817-23. PubMed ID: 1328863
    [Abstract] [Full Text] [Related]

  • 5. The role of viral enhancer "core" motif-related sequences in regulating T cell receptor-gamma and -delta gene expression.
    Hsiang YH, Spencer D, Wang S, Speck NA, Raulet DH.
    J Immunol; 1993 May 01; 150(9):3905-16. PubMed ID: 8473739
    [Abstract] [Full Text] [Related]

  • 6. Characterization of a protein that binds multiple sequences in mammalian type C retrovirus enhancers.
    Sun W, O'Connell M, Speck NA.
    J Virol; 1993 Apr 01; 67(4):1976-86. PubMed ID: 8445719
    [Abstract] [Full Text] [Related]

  • 7. Core-binding factor influences the disease specificity of Moloney murine leukemia virus.
    Lewis AF, Stacy T, Green WR, Taddesse-Heath L, Hartley JW, Speck NA.
    J Virol; 1999 Jul 01; 73(7):5535-47. PubMed ID: 10364302
    [Abstract] [Full Text] [Related]

  • 8. Mutation of the core or adjacent LVb elements of the Moloney murine leukemia virus enhancer alters disease specificity.
    Speck NA, Renjifo B, Golemis E, Fredrickson TN, Hartley JW, Hopkins N.
    Genes Dev; 1990 Feb 01; 4(2):233-42. PubMed ID: 2338244
    [Abstract] [Full Text] [Related]

  • 9. In vivo footprinting of the enhancer sequences in the upstream long terminal repeat of Moloney murine leukemia virus: differential binding of nuclear factors in different cell types.
    Granger SW, Fan H.
    J Virol; 1998 Nov 01; 72(11):8961-70. PubMed ID: 9765441
    [Abstract] [Full Text] [Related]

  • 10. Point mutations in the Moloney murine leukemia virus enhancer identify a lymphoid-specific viral core motif and 1,3-phorbol myristate acetate-inducible element.
    Speck NA, Renjifo B, Hopkins N.
    J Virol; 1990 Feb 01; 64(2):543-50. PubMed ID: 2104942
    [Abstract] [Full Text] [Related]

  • 11. Transactivation of the Moloney murine leukemia virus and T-cell receptor beta-chain enhancers by cbf and ets requires intact binding sites for both proteins.
    Sun W, Graves BJ, Speck NA.
    J Virol; 1995 Aug 01; 69(8):4941-9. PubMed ID: 7609063
    [Abstract] [Full Text] [Related]

  • 12. Second-site proviral enhancer alterations in lymphomas induced by enhancer mutants of SL3-3 murine leukemia virus: negative effect of nuclear factor 1 binding site.
    Ethelberg S, Hallberg B, Lovmand J, Schmidt J, Luz A, Grundström T, Pedersen FS.
    J Virol; 1997 Feb 01; 71(2):1196-206. PubMed ID: 8995642
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Stability of AML1 (core) site enhancer mutations in T lymphomas induced by attenuated SL3-3 murine leukemia virus mutants.
    Amtoft HW, Sørensen AB, Bareil C, Schmidt J, Luz A, Pedersen FS.
    J Virol; 1997 Jul 01; 71(7):5080-7. PubMed ID: 9188573
    [Abstract] [Full Text] [Related]

  • 18. Murine helix-loop-helix transcriptional activator proteins binding to the E-box motif of the Akv murine leukemia virus enhancer identified by cDNA cloning.
    Nielsen AL, Pallisgaard N, Pedersen FS, Jørgensen P.
    Mol Cell Biol; 1992 Aug 01; 12(8):3449-59. PubMed ID: 1321336
    [Abstract] [Full Text] [Related]

  • 19. Distinct segments within the enhancer region collaborate to specify the type of leukemia induced by nondefective Friend and Moloney viruses.
    Golemis E, Li Y, Fredrickson TN, Hartley JW, Hopkins N.
    J Virol; 1989 Jan 01; 63(1):328-37. PubMed ID: 2783259
    [Abstract] [Full Text] [Related]

  • 20. Identification of ETS domain proteins in murine T lymphocytes that interact with the Moloney murine leukemia virus enhancer.
    Gunther CV, Graves BJ.
    Mol Cell Biol; 1994 Nov 01; 14(11):7569-80. PubMed ID: 7935472
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.